UniProt ID | CAN1_HUMAN | |
---|---|---|
UniProt AC | P07384 | |
Protein Name | Calpain-1 catalytic subunit {ECO:0000305} | |
Gene Name | CAPN1 {ECO:0000312|HGNC:HGNC:1476} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 714 | |
Subcellular Localization | Cytoplasm . Cell membrane . Translocates to the plasma membrane upon Ca(2+) binding. In granular keratinocytes and in lower corneocytes, colocalizes with FLG and FLG2 (PubMed:21531719). | |
Protein Description | Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction.. | |
Protein Sequence | MSEEIITPVYCTGVSAQVQKQRARELGLGRHENAIKYLGQDYEQLRVRCLQSGTLFRDEAFPPVPQSLGYKDLGPNSSKTYGIKWKRPTELLSNPQFIVDGATRTDICQGALGDCWLLAAIASLTLNDTLLHRVVPHGQSFQNGYAGIFHFQLWQFGEWVDVVVDDLLPIKDGKLVFVHSAEGNEFWSALLEKAYAKVNGSYEALSGGSTSEGFEDFTGGVTEWYELRKAPSDLYQIILKALERGSLLGCSIDISSVLDMEAITFKKLVKGHAYSVTGAKQVNYRGQVVSLIRMRNPWGEVEWTGAWSDSSSEWNNVDPYERDQLRVKMEDGEFWMSFRDFMREFTRLEICNLTPDALKSRTIRKWNTTLYEGTWRRGSTAGGCRNYPATFWVNPQFKIRLDETDDPDDYGDRESGCSFVLALMQKHRRRERRFGRDMETIGFAVYEVPPELVGQPAVHLKRDFFLANASRARSEQFINLREVSTRFRLPPGEYVVVPSTFEPNKEGDFVLRFFSEKSAGTVELDDQIQANLPDEQVLSEEEIDENFKALFRQLAGEDMEISVKELRTILNRIISKHKDLRTKGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRIRNYLSIFRKFDLDKSGSMSAYEMRMAIESAGFKLNKKLYELIITRYSEPDLAVDFDNFVCCLVRLETMFRFFKTLDTDLDGVVTFDLFKWLQLTMFA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSEEIITPV ------CCCCCCCCE | 43.89 | 30108239 | |
2 | Acetylation | ------MSEEIITPV ------CCCCCCCCE | 43.89 | 19413330 | |
20 | Ubiquitination | GVSAQVQKQRARELG CHHHHHHHHHHHHCC | 42.78 | - | |
36 | Ubiquitination | GRHENAIKYLGQDYE CCHHHHHHHHCCCHH | 31.82 | 21906983 | |
37 | Phosphorylation | RHENAIKYLGQDYEQ CHHHHHHHHCCCHHH | 15.22 | 29496907 | |
42 | Phosphorylation | IKYLGQDYEQLRVRC HHHHCCCHHHHHHHH | 9.55 | 28796482 | |
52 | Phosphorylation | LRVRCLQSGTLFRDE HHHHHHHCCCCCCCC | 22.31 | 24505115 | |
54 | Phosphorylation | VRCLQSGTLFRDEAF HHHHHCCCCCCCCCC | 28.15 | 24505115 | |
71 | Ubiquitination | VPQSLGYKDLGPNSS CCCCCCCCCCCCCCC | 44.68 | 21906983 | |
77 | Phosphorylation | YKDLGPNSSKTYGIK CCCCCCCCCCCCCCC | 36.02 | 12843408 | |
78 | Phosphorylation | KDLGPNSSKTYGIKW CCCCCCCCCCCCCCC | 35.34 | 12843408 | |
79 | Ubiquitination | DLGPNSSKTYGIKWK CCCCCCCCCCCCCCC | 45.66 | 21906983 | |
80 | Phosphorylation | LGPNSSKTYGIKWKR CCCCCCCCCCCCCCC | 29.00 | 12843408 | |
81 | Phosphorylation | GPNSSKTYGIKWKRP CCCCCCCCCCCCCCC | 22.16 | 12843408 | |
84 | Ubiquitination | SSKTYGIKWKRPTEL CCCCCCCCCCCCHHH | 42.15 | 21906983 | |
84 | Acetylation | SSKTYGIKWKRPTEL CCCCCCCCCCCCHHH | 42.15 | 19608861 | |
86 | Ubiquitination | KTYGIKWKRPTELLS CCCCCCCCCCHHHHC | 43.42 | - | |
89 | Phosphorylation | GIKWKRPTELLSNPQ CCCCCCCHHHHCCCE | 43.21 | 28450419 | |
93 | Phosphorylation | KRPTELLSNPQFIVD CCCHHHHCCCEEEEC | 60.12 | 26657352 | |
193 | Ubiquitination | FWSALLEKAYAKVNG HHHHHHHHHHHHHCC | 46.82 | 21906983 | |
229 | Ubiquitination | TEWYELRKAPSDLYQ CCHHHHHCCCCHHHH | 76.81 | 21906983 | |
229 | Trimethylation | TEWYELRKAPSDLYQ CCHHHHHCCCCHHHH | 76.81 | - | |
229 | Methylation | TEWYELRKAPSDLYQ CCHHHHHCCCCHHHH | 76.81 | - | |
232 | Phosphorylation | YELRKAPSDLYQIIL HHHHCCCCHHHHHHH | 45.14 | 26657352 | |
235 | Phosphorylation | RKAPSDLYQIILKAL HCCCCHHHHHHHHHH | 11.58 | 28152594 | |
240 | Ubiquitination | DLYQIILKALERGSL HHHHHHHHHHHHCCC | 40.28 | - | |
251 | Phosphorylation | RGSLLGCSIDISSVL HCCCCCCCCCHHHHC | 22.84 | 24719451 | |
255 | Phosphorylation | LGCSIDISSVLDMEA CCCCCCHHHHCCCCE | 15.62 | - | |
256 | Phosphorylation | GCSIDISSVLDMEAI CCCCCHHHHCCCCEE | 27.34 | 24719451 | |
270 | Acetylation | ITFKKLVKGHAYSVT EEHHHHHCCCCEEEE | 56.25 | 25953088 | |
270 | Ubiquitination | ITFKKLVKGHAYSVT EEHHHHHCCCCEEEE | 56.25 | - | |
280 | Ubiquitination | AYSVTGAKQVNYRGQ CEEEECCEEECCCCE | 57.00 | 21906983 | |
290 | Phosphorylation | NYRGQVVSLIRMRNP CCCCEEEEEEEEECC | 21.15 | 26437602 | |
328 | Ubiquitination | ERDQLRVKMEDGEFW HHHHEEEEECCCCCE | 30.09 | 21906983 | |
337 | Phosphorylation | EDGEFWMSFRDFMRE CCCCCEEHHHHHHHH | 14.02 | 24719451 | |
354 | Phosphorylation | RLEICNLTPDALKSR CHHHHCCCHHHHHHC | 12.72 | 27153400 | |
359 | Malonylation | NLTPDALKSRTIRKW CCCHHHHHHCCCCCC | 39.34 | 26320211 | |
359 | Acetylation | NLTPDALKSRTIRKW CCCHHHHHHCCCCCC | 39.34 | 25953088 | |
359 | Ubiquitination | NLTPDALKSRTIRKW CCCHHHHHHCCCCCC | 39.34 | - | |
360 | Phosphorylation | LTPDALKSRTIRKWN CCHHHHHHCCCCCCC | 35.19 | 12843408 | |
362 | Phosphorylation | PDALKSRTIRKWNTT HHHHHHCCCCCCCCE | 32.02 | 12843408 | |
365 | Ubiquitination | LKSRTIRKWNTTLYE HHHCCCCCCCCEEEE | 40.73 | 21890473 | |
368 | Phosphorylation | RTIRKWNTTLYEGTW CCCCCCCCEEEEEEC | 19.64 | 23882029 | |
369 | Phosphorylation | TIRKWNTTLYEGTWR CCCCCCCEEEEEECC | 24.91 | 28152594 | |
371 | Phosphorylation | RKWNTTLYEGTWRRG CCCCCEEEEEECCCC | 15.38 | 20090780 | |
374 | Phosphorylation | NTTLYEGTWRRGSTA CCEEEEEECCCCCCC | 12.12 | 28152594 | |
379 | Phosphorylation | EGTWRRGSTAGGCRN EEECCCCCCCCCCCC | 17.17 | 27273156 | |
380 | Phosphorylation | GTWRRGSTAGGCRNY EECCCCCCCCCCCCC | 31.95 | 12843408 | |
387 | Phosphorylation | TAGGCRNYPATFWVN CCCCCCCCCEEEEEC | 3.79 | 20090780 | |
390 | Phosphorylation | GCRNYPATFWVNPQF CCCCCCEEEEECCCE | 17.33 | 23882029 | |
398 | Ubiquitination | FWVNPQFKIRLDETD EEECCCEEEECCCCC | 22.97 | 21890473 | |
404 | Phosphorylation | FKIRLDETDDPDDYG EEEECCCCCCCCCCC | 45.42 | - | |
410 | Phosphorylation | ETDDPDDYGDRESGC CCCCCCCCCCCHHHH | 28.45 | 23532336 | |
415 | Phosphorylation | DDYGDRESGCSFVLA CCCCCCHHHHHHHHH | 46.09 | - | |
418 | Phosphorylation | GDRESGCSFVLALMQ CCCHHHHHHHHHHHH | 23.16 | - | |
438 | Sulfoxidation | ERRFGRDMETIGFAV HHHHCCCHHHHEEEE | 4.76 | 30846556 | |
446 | Phosphorylation | ETIGFAVYEVPPELV HHHEEEEEECCHHHC | 14.05 | 12843408 | |
461 | Ubiquitination | GQPAVHLKRDFFLAN CCCEEECCCCCHHHC | 34.74 | 21906983 | |
470 | Phosphorylation | DFFLANASRARSEQF CCHHHCCHHHHCHHH | 26.70 | 28060719 | |
474 | Phosphorylation | ANASRARSEQFINLR HCCHHHHCHHHCCHH | 34.46 | 28450419 | |
494 | Phosphorylation | FRLPPGEYVVVPSTF CCCCCCCEEEECCCC | 12.40 | - | |
499 | Phosphorylation | GEYVVVPSTFEPNKE CCEEEECCCCCCCCC | 33.83 | 20071362 | |
505 | Ubiquitination | PSTFEPNKEGDFVLR CCCCCCCCCCCEEEE | 74.02 | 21890473 | |
539 | Phosphorylation | LPDEQVLSEEEIDEN CCCHHCCCHHHHHHH | 44.07 | - | |
559 | Sulfoxidation | RQLAGEDMEISVKEL HHHCCCCCCCCHHHH | 4.25 | 21406390 | |
564 | Ubiquitination | EDMEISVKELRTILN CCCCCCHHHHHHHHH | 44.21 | 2190698 | |
575 | Phosphorylation | TILNRIISKHKDLRT HHHHHHHHHCCCHHC | 26.74 | 29978859 | |
583 | 2-Hydroxyisobutyrylation | KHKDLRTKGFSLESC HCCCHHCCCCCHHHH | 52.07 | - | |
583 | Malonylation | KHKDLRTKGFSLESC HCCCHHCCCCCHHHH | 52.07 | 26320211 | |
583 | Ubiquitination | KHKDLRTKGFSLESC HCCCHHCCCCCHHHH | 52.07 | - | |
622 | Phosphorylation | NRIRNYLSIFRKFDL HHHHHHHHHHHHCCC | 14.88 | 28857561 | |
634 | Phosphorylation | FDLDKSGSMSAYEMR CCCCCCCCCCHHHHH | 19.36 | 25332170 | |
636 | Phosphorylation | LDKSGSMSAYEMRMA CCCCCCCCHHHHHHH | 29.42 | - | |
638 | Phosphorylation | KSGSMSAYEMRMAIE CCCCCCHHHHHHHHH | 11.71 | 25332170 | |
642 | Sulfoxidation | MSAYEMRMAIESAGF CCHHHHHHHHHHCCC | 4.20 | 30846556 | |
646 | Phosphorylation | EMRMAIESAGFKLNK HHHHHHHHCCCCCCH | 27.81 | 25332170 | |
656 | Phosphorylation | FKLNKKLYELIITRY CCCCHHHHHHHHHCC | 19.98 | 28152594 | |
691 | Phosphorylation | TMFRFFKTLDTDLDG HHHHHHHHCCCCCCC | 25.39 | 28387310 | |
701 | Phosphorylation | TDLDGVVTFDLFKWL CCCCCEEEHHHHHHH | 14.71 | 28387310 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
255 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
256 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
415 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
418 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
474 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAN1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAN1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-84, AND MASS SPECTROMETRY. |